Stay updated on Volitinib for Primary CNS Tumors Clinical Trial
Sign up to get notified when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.

Latest updates to the Volitinib for Primary CNS Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This is a minor administrative update with no changes to study information.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe revision history now shows a new entry for v3.4.2, replacing v3.4.1. This is a minor metadata update and does not alter study information.SummaryDifference0.0%

- Check39 days agoChange DetectedA minor revision from v3.4.0 to v3.4.1 was issued; no visible changes to core content or study details are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedGlossary toggle is now visible on the page. Footer metadata has been updated to show 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the previous labels.SummaryDifference0.2%

- Check62 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3, reflecting a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded a Locations section listing study sites (California, Colorado, District of Columbia, Illinois, New York, Ohio, Pennsylvania, Tennessee, Texas, Ontario). Updated revision tag from v3.3.2 to v3.3.3.SummaryDifference1.0%

Stay in the know with updates to Volitinib for Primary CNS Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.